Influence of CYP3A5 genotype of donor and recipient on tacrolimus concentration/dose ratio in early postoperative period of children living related liver transplantation
10.3760/cma.j.issn.0254-1785.2018.07.007
- VernacularTitle:供受体CYP3A5基因分型对儿童亲属活体肝移植后早期他克莫司药物浓度/剂量比的影响
- Author:
Yuexia LI
1
;
Yi ZHANG
;
Yan ZHANG
;
Xiaoshuo WANG
;
Chao SUN
;
Peng FU
;
Shujuan LI
;
Hao FENG
Author Information
1. 300192,天津市第一中心医院药学部
- Keywords:
pediatric living related liver transplantation;
CYP3A5;
tacrolimus;
concentration/dose ratio
- From:
Chinese Journal of Organ Transplantation
2018;39(7):412-417
- CountryChina
- Language:Chinese
-
Abstract:
Objective To provide a reference for the individualized medication of tacrolimus in children after living related liver transplantation,according to the effect of CYP3A5 genotyping on the concentration/dose ratio of tacrolimus in children with living related liver transplantation.Methods Peripheral blood samples were collected from children with living related liver transplantation in the transplant center.The CYP3A5 genotype was determined by polymerase chain reaction (PCR)pyrosequencing.Related indicators such as tacrolimus dose and concentration in children with living related liver transplantation were collected within 3 months after operation.According to the donor/receptor genotype,the donor/receptor expression group,the donor/receptor single expression group,and the donor/receptor non-expression group were set up.Tacrolimus concentration/dose (C0/D) ratio was statistically analyzed at 5th day,7th day,14th day,28th day,2nd month and 3rd month after administration.Results Among the 76 patients,there were 21 patients (27.63％) in CYP3A5 donor/receptor non-expression group,27 patients (35.53％) in donor/receptor single expression group,and 28 patients (36.84％) in the donor/receptor expression group.The time to the target concentration range (C0＞8 ng/mL) in CYP3A5 donor/receptor expression group was longer than in donor/receptor single expression group and donor/receptor non-expression group.Except for the individual time points,there were significant differences between CYP3A5 donor/receptor expression group and donor/receptor non expression group,or between donor/receptor non-expression group and donor/receptor single expression group,or between donor/receptor expression group and donor/receptor single expression group at rest time points (P＜0.05 for all).Conclusion In the CYP3A5 donor/receptor gene expression group,the higher dose was needed to reach the target concentration range than the gene single expression group and the donor/receptor non-expression group.Except for individual time points,there were significant differences in C0/D at rest different time points.Regardless of whether the donor or recipient contained the CYP3A5* 1 allele,C0/D was lower than the non-expressed type of the gene.Considering the polymorphism of the donor/receptor CYP3A5 gene,it was worthful for children with living related liver transplantation to allow the drug concentration to reach the therapeutic window as soon as possible and reduce organ rejection and adverse reactions.
